The Department of Cardiovascular & Metabolic Sciences is home to scientists with broad expertise in cardiovascular and related systems as well as cellular metabolism related to diabetes, cancer and heart disease.
More About UsThe Luse lab studies molecular events that drive promoter recognition and transcription of genes in chromosomes.
Learn MoreThe Perez lab discerns the roles of α1-adrenergic receptor subtypes in physiological and pathophysiological states.
Learn MoreThe Reizes lab studies ovarian cancer and triple negative breast cancer, focusing on novel therapeutic development.
Learn MoreRecent cardiovascular research at Cleveland Clinic examined topics such as the gut microbiome connection to the heart, COVID-19’s impact on cardiac event risk and improving cardiac imaging.
Two leading atrial fibrillation researchers with Cleveland Clinic’s TRIM-AF trial shared initial results about metformin’s effects on AF, and what’s next for research.
Dr. Matthew Grabowski received an American Cancer Society Clinician Scientist Development Grant to study a potential new treatment target for glioblastoma.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Cardiovascular & Metabolic Sciences.
View Careers